Dr Hoenle AG (XTER:HNL) Debt-to-Equity : 0.59 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Debt-to-Equity?

Dr Hoenle AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €13.2 Mil. Dr Hoenle AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €41.8 Mil. Dr Hoenle AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €93.3 Mil. Dr Hoenle AG's debt to equity for the quarter that ended in Dec. 2023 was 0.59.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Dr Hoenle AG's Debt-to-Equity or its related term are showing as below:

XTER:HNL' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07 Med: 0.26 Max: 0.59
Current: 0.59

During the past 13 years, the highest Debt-to-Equity Ratio of Dr Hoenle AG was 0.59. The lowest was 0.07. And the median was 0.26.

XTER:HNL's Debt-to-Equity is ranked worse than
71.05% of 2622 companies
in the Industrial Products industry
Industry Median: 0.29 vs XTER:HNL: 0.59

Dr Hoenle AG Debt-to-Equity Historical Data

The historical data trend for Dr Hoenle AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Debt-to-Equity Chart

Dr Hoenle AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Equity

Get a 7-Day Free Trial

0.18

0.40

0.48

0.56

0.59

Dr Hoenle AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.52	0.52	0.57	0.59	0.59

Competitive Comparison of Dr Hoenle AG's Debt-to-Equity

For the Electrical Equipment & Parts subindustry, Dr Hoenle AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Hoenle AG's Debt-to-Equity Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Dr Hoenle AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dr Hoenle AG's Debt-to-Equity falls into.

Dr Hoenle AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dr Hoenle AG's Debt to Equity Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.748	+	43.143)	/	95.82
	=	0.59

Dr Hoenle AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.206	+	41.772)	/	93.25
	=	0.59

Dr Hoenle AG (XTER:HNL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dr Hoenle AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Hoenle AG (XTER:HNL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

HNL:Germany HNL:Germany

Address

Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205

Website

https://www.hoenle.de

Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines